Safe Therapeutics was an overall app developed by Safe Therapeutics. It was removed from Google Play Jun 17, 2024 and is no longer available for download.
Download Statistics
User Ratings
The app had no ratings.
App Information
Safe Therapeutics was free to download. The APK download size was 22.98 MB. The last available version was 1.2. The last update was on May 31, 2024.
Technical Requirements
The app had a content rating of Medium Maturity. The app had been available on Google Play August 2023.
Description
SafeTherapeutics is a mobile application which inform individuals immediately about whether their drugs are causing adverse drug reactions (ADR). We created and used a patented unique database extracting adverse drug effect data from millions of documents. The database is updated quarterly, and all the underlying documentation can be supplied to each patient’s healthcare provider. The SafeTherapeutics Platform is the only patient or problem-centric search platform for the clinical management of problems with your medications. Individuals enter their symptoms or problems from easy-to-navigate dropdown lists. Medications are entered by typing a few letters using a smart search, scanning their prescription labels. Once loaded, a single click will produce a display of potential ADR relationships, with the results seen within seconds. Results are color-coded like a ‘traffic light’ and severe problems are clearly flagged. Once the search is completed, the search results can easily be forwarded to the healthcare provider with links to the actual data and scientific based content. We know you will make use of the SafeTherapeutics App and learn a great deal to guide your health and wellness.
App's functionality is paid and subscription-based. There is no free basic functionality.
Terms of Use: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Each subscription will automatically renew 3 days before the expiration date for
the same time period. Subscriptions can be cancelled at any time before the renewal.